Bell’s Palsy Treatment Demand Propelled by Growing Prevalence of Bell’s Palsy, Says Fact.MR

Fact.MR, a global research & consulting firm, in their latest edition of the report, indicated that the bell’s palsy treatment market will register an exponential growth in 2021 and beyond. The growth can be primarily driven by higher prevalence of cardiovascular ailments, growing rate of strokes, cumulative inflammation rates, launch of technically progressed devices, as well as increasing penetration by market players. Furthermore, aspects such as government support and initiatives, and growing cardiologic anomalies reimbursement will be driving the Bell’s palsy treatment industry.

Leading pharmaceutical players are focusing on manufacturing better-quality drugs through research and development activities for Bell’s palsy treatment, which is further responsible for the robust expansion of the bells palsy treatment industry.” states Fact.MR.

Lower Cost of Maintenance & Installation Augments the Demand 

A projected incidence of 15–30 instances per 100,000 populations, annually has been acknowledged by several population based studies. An estimate of 60–75% instances of severe unilateral facial paralysis has been stated. Growing prevalence of ear and eye infections, are the major causes of Bell’s palsy in addition to the unfavorable lifestyle changes of individuals. In addition, growing awareness amid individuals about the treatment of Bell’s palsy is likely to boost its demand over the assessment period. 

 For more insights into the Market, Request a Sample of this Report

Corticosteroids is Anticipated to Remain Lucrative

Corticosteroids and anticonvulsants, are likely to jointly gain traction, across the globe. Both anticonvulsants and corticosteroids are majorly preferred as the first line of therapy by physicians for the Bell’s palsy treatment. These drugs are offered in amalgamation with anti-viral and anti-bacterial medications.

These drugs are widely available in online pharmacies and drug stores. Furthermore, corticosteroids have reflected positive outcomes for the treatment if started in a few days of symptom existence and assist in decreasing the facial nerves swelling. 

The US will Remain Lucrative, Trailed by The UK

The US, followed by Germany, Italy, U.K, and Russia will be gaining highest market share in revenue terms due to increasing awareness amid individuals in relation to the treatment Bell’s palsy.

The UK and Russia will foresee growth due to the existence of the highest number of pharmaceutical companies.

India, China, New Zealand & Australia is projected to expand at a faster pace in contrast to other regions owing to the increasing cases of Bell’s palsy. India and China will remain most prevalent in the industry.

Get Customization on this Report for Specific Country

New Product Launches & Expansions Remain Major Focal Points: Fact.MR Survey

The bell’s palsy treatment market appears highly fragmented in nature. Fact.MR’s survey indicated that the leading market players are focusing on expansions, new product launches, agreements, partnerships, joint ventures, acquisitions, along with others to boost their impressions in this industry. The latest edition of the report offers comprehensive coverage of the anticipated to remain the significant strategies of companies. A few of the players profiled in the report are Bristol-Myers Squibb and Company, Pfizer Inc., Eli Lily and Company, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Bayer AG, Novartis AG, Sanofi S.A., Gilead Sciences, Inc. and Teva Pharmaceutical Industries Ltd. The latest edition also provides a detailed analysis of the COVID-19 impact on this market.

Explore Fact.MR’s Healthcare Reports

Ultrasound Systems Market: Delve into Fact.MR’s extensive study on the Ultrasound Systems market, offering detailed assessment. The study analyses crucial trends that are currently determining, and those which are expected to shape future expansion trajectory, shedding light on the vital dynamics such as drivers, restraints and opportunities.

Glaucoma Therapeutics Market: The global Glaucoma Therapeutics market study published by incorporates detailed assessment of the market landscape, taking into consideration value chain analysis, business execution and supply chain analysis across key markets.

Antibacterial Washcloth Market: Fact.MR’s global Antibacterial Washcloth market research report provides stakeholders with an exhaustive analysis on key market dynamics, such as the drivers, restraints, opportunities and trends responsible for shaping the future expansion trajectory.


Sudip Saha

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583


Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Source: Fact.MR

Back to news